Ken Griffin Neogenomics Inc Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neogenomics Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 135,000 shares of NEO stock, worth $2.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

135,000

Previous 152,000 11.18%

Holding current value

$2.27 Million

Previous $2.11 Million 5.55%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.4 - $17.73 $257,628 - $340,876	19,226 New	19,226 $283,000
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $3.24 Million - $5.76 Million	-277,918 Reduced 88.63%	35,654 $576,000
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $2.15 Million - $3.15 Million	-176,645 Reduced 36.03%	313,572 $3.86 Million
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $13.1 Million - $18.4 Million	-927,888 Reduced 65.43%	490,217 $7.88 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $7.47 Million - $16 Million	822,320 Added 138.02%	1,418,105 $24.7 Million
Q4 2022 Feb 14, 2023	SELL	$6.45 - $12.07 $4.07 Million - $7.61 Million	-630,698 Reduced 51.42%	595,785 $5.51 Million
Q3 2022 Nov 14, 2022	BUY	$7.86 - $12.91 $2.17 Million - $3.57 Million	276,458 Added 29.1%	1,226,483 $10.6 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $2.17 Million - $4.3 Million	307,862 Added 47.94%	950,025 $7.74 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $35.28 $4.07 Million - $11.8 Million	335,294 Added 109.26%	642,163 $7.8 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $8.36 Million - $13.3 Million	274,192 Added 839.1%	306,869 $10.5 Million
Q3 2021 Nov 15, 2021	SELL	$41.66 - $52.52 $2.72 Million - $3.42 Million	-65,188 Reduced 66.61%	32,677 $1.58 Million
Q2 2021 Aug 16, 2021	SELL	$36.62 - $51.69 $320,534 - $452,442	-8,753 Reduced 8.21%	97,865 $4.42 Million
Q1 2021 May 17, 2021	BUY	$41.56 - $59.88 $1.4 Million - $2.02 Million	33,678 Added 46.17%	106,618 $5.14 Million
Q4 2020 Feb 16, 2021	SELL	$36.08 - $56.47 $136,923 - $214,303	-3,795 Reduced 4.95%	72,940 $3.93 Million
Q3 2020 Nov 16, 2020	SELL	$33.26 - $40.48 $374,707 - $456,047	-11,266 Reduced 12.8%	76,735 $2.83 Million
Q1 2020 May 15, 2020	SELL	$20.5 - $34.53 $1.01 Million - $1.71 Million	-49,431 Reduced 35.97%	88,001 $2.43 Million
Q4 2019 Feb 14, 2020	SELL	$18.96 - $29.84 $2.03 Million - $3.19 Million	-106,864 Reduced 43.74%	137,432 $4.02 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $26.24 $816,653 - $1.12 Million	42,712 Added 21.19%	244,296 $4.67 Million
Q2 2019 Aug 14, 2019	SELL	$19.57 - $24.1 $10.5 Million - $12.9 Million	-536,639 Reduced 72.69%	201,584 $4.42 Million
Q4 2018 Feb 14, 2019	BUY	$11.24 - $18.5 $3.69 Million - $6.08 Million	328,395 Added 80.13%	738,223 $9.31 Million
Q3 2018 Nov 13, 2018	SELL	$12.5 - $15.38 $195,650 - $240,727	-15,652 Reduced 3.68%	409,828 $0
Q2 2018 Aug 10, 2018	BUY	$7.99 - $14.05 $436,142 - $766,933	54,586 Added 14.72%	425,480 $0
Q1 2018 May 11, 2018	BUY	$7.23 - $8.76 $1.05 Million - $1.27 Million	145,440 Added 64.51%	370,894 $3.03 Million
Q4 2017 Feb 09, 2018	BUY	$8.02 - $11.18 $127,790 - $178,142	15,934 Added 7.61%	225,454 $2 Million
Q3 2017 Nov 09, 2017	BUY	$9.11 - $11.26 $1.91 Million - $2.36 Million	209,520	209,520 $2.33 Million

Others Institutions Holding NEO

# of Institutions

294

Shares Held

124M

Call Options Held

698K

Put Options Held

120K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.12B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account